| About the author: |
Tarianyk K.A., Lytvynenko N.V., Oliinychenko V.K., Byslik T.V., Pochernyaev K.F. |
| Heading |
CLINICAL MEDICINE |
| Type of article |
Scentific article |
| Annotation |
The article suggests the polymerase chain reaction-restriction fragment length polymorphism method for a single nucleotide polymorphism (rs2583988) detection for further prediction of Parkinson’s disease risks. Based on the meta-analysis results for the single nucleotide polymorphism rs2583988 (C>T) in αlpha-synuclein gene; current polymorphic variant was chosen by analyzing bioinformatical and genetic studies. We have designed a pair of primers and conditions for restriction analysis to detect different alleles in rs2583988. As a result, there was developed a simple and affordable method for detecting single nucleotide polymorphism rs2583988 alleles. The method is expected to be suitable for clinic laboratories, due to affordable cost and equipment, and to be used in further association studies. |
| Tags |
Parkinson’s disease, αlpha-synuclein gene, single nucleotide polymorphism, polymerase chain reaction-restriction fragment length polymorphism |
| Bibliography |
- Campelo CLC, Cagni FC, de Siqueira Figueredo D, Oliveira LG. Variants in SNCA gene are associated with Parkinson's disease risk and cognitive symptoms in a Brazilian sample. Front aging neurosci. 2017; 9: 198-204.
- Caslake R, Taylor K, Scott N, et al. Age-, gender-, and socioeconomic status-specific incidence of Parkinson's disease and parkinsonism in northeast Scotland: the PINE study. Parkinsonism Relat Disord. 2013; 19(5): 515-521.
- Elbaz A, Ross OA, Ioannidis JP, Soto-Ortolaza AI, Moisan F, Aasly J, Annesi G, Bozi M, Brighina L, Chartier-Harlin MC. Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium. Independent and joint effects of the MAPT and SNCA genes in Parkinson disease. Ann Neurol. 2011; 69(5): 778-92.
- Emelyanov A, Kulabukhova D, Garaeva L. SNCA variants and alpha-synuclein level in CD45+ blood cells in Parkinson's disease. J Neurol Sci. 2018; 395: 135-140.
- Han W, Liu Y, Mi Y, Zhao J, Liu D, Tian Q. Alpha-synuclein (SNCA) polymorphisms and susceptibility to Parkinson's disease: a meta-analysis. Med Genet. 2015; 168 (2): 123-34.
- Homo sapiens synuclein alpha (SNCA), transcript variant 4, mRNA - Nucleotide – NCBI https://www.ncbi.nlm.nih.gov/nuccore/NM_007308.
- Iakovenko EV, Abramycheva NY, Fedotova EY, Illarioshkin SN. The SNCA-Rep1 Polymorphic Locus: Association with the Risk of Parkinson's Disease and SNCA Gene Methylation. Acta Naturae. 2020; 12(2): 105-110.
- Linnertz C, Lutz MW, Ervin JF, Allen J, Miller NR, Welsh-Bohmer KA, Roses AD, Chiba-Falek O. The genetic contributions of SNCA and LRRK2 genes to Lewy Body pathology in Alzheimer's disease. Hum Mol Genet. 2014; 23(18): 4814-21.
- McCarthy JJ, Linnertz C, Saucier L, et al. The effect of SNCA 3' region on the levels of SNCA-112 splicing variant. Neurogenetics. 2011; 12(1): 59-64.
- Primer designing tool https://www.ncbi.nlm.nih.gov/tools/primer-blast/
- Szigeti E. Nursing care of patients with Parkinson's disease. Neurosci Biobehav Rev. 1988 Fall-Winter; 12(3-4): 307-309.
- Toffoli M, Dreussi E, Cecchin E, et al. SNCA 3'UTR genetic variants in patients with Parkinson's disease and REM sleep behavior disorder. Neurol Sci. 2017; 38(7): 1233-1240.
- Walsh PS, Metzger DA, Higushi R. Chelex 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material. BioTechniques. 2013; 10(4): 506-13.
- Zhang Y, Shu L, Sun Q, Pan H, Guo J, Tang B. A Comprehensive Analysis of the Association Between SNCA Polymorphisms and the Risk of Parkinson's Disease. Front Mol Neurosci. 2018; 11:391-95.
|
| Publication of the article |
«World of Medicine and Biology» №3(73), 2020 year, 130-134 pages, index UDK 616.858-008.6:575 |
| DOI |
10.26724/2079-8334-2020-3-73-130-134 |
